Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor

Frank G. Boess, Frederick J. Monsma Jr., Valerie Meyer, Catherine Zwingelstein and Andrew J. Sleight
Molecular Pharmacology September 1997, 52 (3) 515-523; DOI: https://doi.org/10.1124/mol.52.3.515
Frank G. Boess
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick J. Monsma Jr.
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie Meyer
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Zwingelstein
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Sleight
Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 52 no. 3 515-523
DOI 
https://doi.org/10.1124/mol.52.3.515
PubMed 
9284367

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received March 14, 1997
  • Accepted May 19, 1997
  • Published online September 1, 1997.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Frank G. Boess,
  2. Frederick J. Monsma Jr.,
  3. Valerie Meyer,
  4. Catherine Zwingelstein, and
  5. Andrew J. Sleight
  1. Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 1999 to January 2021

AbstractFullPdf
Feb 1999032
Mar 1999134
Apr 1999041
May 1999034
Jun 1999042
Aug 1999232
Sep 1999163
Nov 1999195
Dec 1999011
Feb 2000610
Mar 2000232
Apr 2000055
May 2000073
Jun 2000226
Jul 2000043
Aug 20000410
Sep 2000158
Oct 2000123
Nov 2000242
Dec 2000415
Jan 2001025
Feb 200101111
Mar 2001234
Apr 2001254
May 2001025
Jun 2001023
Jul 2001044
Aug 2001136
Sep 2001101
Oct 2001166
Nov 2001166
Dec 20010108
Jan 2002015
Feb 2002112
Mar 2002087
Apr 2002137
May 2002074
Jun 20020614
Jul 2002154
Aug 2002053
Sep 2002024
Oct 20021610
Nov 2002265
Dec 2002023
Jan 2003012
Feb 20031149
Mar 2003110
Apr 2003265
May 200321012
Jun 2003177
Jul 200311194
Aug 200311214
Sep 200381710
Oct 200362811
Nov 200313284
Dec 2003102313
Jan 2004183222
Feb 2004122613
Mar 200413338
Apr 200472816
May 200462315
Jun 2004192710
Jul 2004192712
Aug 200411228
Sep 200414273
Oct 200410297
Nov 2004142510
Dec 200410326
Jan 200515308
Feb 20054336
Mar 200511225
Apr 200542111
May 20059223
Jun 200510110
Jul 200512195
Aug 20053143
Sep 20054125
Oct 200582110
Nov 20057215
Dec 20056116
Jan 200672311
Feb 20064213
Mar 20062104
Apr 20061146
May 2006372
Jun 20063227
Jul 20062123
Aug 2006595
Sep 2006397
Oct 20062113
Nov 20069164
Dec 2006472
Jan 20073114
Feb 20075139
Mar 20071177
Apr 20076216
May 20072185
Jun 2007292
Jul 2007166
Aug 2007498
Sep 2007461
Oct 20070147
Nov 2007044
Dec 20070186
Jan 2008185
Feb 20083511
Mar 2008975
Apr 20087106
May 200815118
Jun 2008311810
Jul 2008595
Aug 2008385
Sep 2008343
Oct 2008341
Nov 2008293
Dec 20083103
Jan 2009162
Feb 2009153
Mar 200921413
Apr 2009084
May 20096138
Jun 2009462
Jul 2009164
Aug 2009382
Sep 20097110
Oct 2009563
Nov 20091292
Dec 20099116
Jan 20106117
Feb 2010473
Mar 2010232
Apr 20101165
May 20105196
Jun 20104126
Jul 2010232
Aug 2010081
Sep 2010299
Oct 20105117
Nov 20104131
Dec 2010265
Jan 2011244
Feb 20115144
Mar 20115182
Apr 2011363
May 20112135
Jun 20115108
Jul 2011797
Aug 20115105
Sep 20119117
Oct 20118113
Nov 20112133
Dec 2011162
Jan 2012145
Feb 2012556
Mar 2012587
Apr 2012525
May 2012378
Jun 2012573
Jul 2012265
Aug 2012142
Sep 20122244
Oct 2012751
Nov 2012487
Dec 20121044
Jan 20136114
Feb 201361616
Mar 2013835
Apr 2013972
May 20131035
Jun 2013114
Jul 2013018
Aug 2013101
Sep 2013321
Oct 2013156
Nov 2013102
Dec 2013043
Jan 2014624
Feb 2014654
Mar 20145311
Apr 2014173
May 2014145
Jun 2014323
Jul 2014248
Aug 2014034
Sep 2014111
Oct 2014663
Nov 2014579
Dec 2014929
Jan 2015638
Feb 2015013
Mar 2015942
Apr 2015310
May 2015622
Jun 2015310
Jul 20159122
Aug 2015374
Sep 2015052
Oct 2015252
Nov 2015301
Dec 2015022
Jan 2016463
Feb 2016745
Mar 2016608
Apr 2016034
May 2016111
Jun 2016355
Jul 20161139
Aug 2016372
Sep 2016072
Oct 2016153
Nov 2016263
Dec 20162122
Jan 20172100
Feb 20170112
Mar 2017072
Apr 2017081
May 20170122
Jun 20170111
Jul 20171111
Aug 20170121
Sep 20170123
Oct 20170142
Nov 20170130
Dec 20170191
Jan 20180242
Feb 20182207
Mar 20180164
Apr 20182171
May 20181181
Jun 20180232
Jul 20180114
Aug 2018180
Sep 20180183
Oct 20180574
Nov 20181643
Dec 20183351
Jan 20194911
Feb 20192000
Mar 20191600
Apr 2019511
May 2019803
Jun 2019812
Jul 2019200
Aug 2019411
Sep 2019832
Oct 2019812
Nov 20192111
Dec 20191411
Jan 2020522
Feb 2020700
Mar 2020300
Apr 20201200
May 2020301
Jun 20201000
Jul 2020800
Aug 2020101
Sep 2020100
Oct 2020300
Nov 2020800
Dec 20201000
Jan 20211370

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 52 (3)
Molecular Pharmacology
Vol. 52, Issue 3
1 Sep 1997
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor

Frank G. Boess, Frederick J. Monsma, Valerie Meyer, Catherine Zwingelstein and Andrew J. Sleight
Molecular Pharmacology September 1, 1997, 52 (3) 515-523; DOI: https://doi.org/10.1124/mol.52.3.515

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor

Frank G. Boess, Frederick J. Monsma, Valerie Meyer, Catherine Zwingelstein and Andrew J. Sleight
Molecular Pharmacology September 1, 1997, 52 (3) 515-523; DOI: https://doi.org/10.1124/mol.52.3.515
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CTS bias
  • Nelfinavir and PXR
  • P2X7 Positive Modulator Structure-Activity Relationship
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics